has been cited by the following article(s):
[1]
|
Global Women's Health
2021
DOI:10.5772/intechopen.101239
|
|
|
[2]
|
Sex and Gender Disparities in Melanoma
Cancers,
2020
DOI:10.3390/cancers12071819
|
|
|
[3]
|
Cutaneous Melanoma [Working Title]
2019
DOI:10.5772/intechopen.86593
|
|
|
[4]
|
Cancer Prognosis
2018
DOI:10.5772/intechopen.76499
|
|
|
[5]
|
Quantitative comparison of the spreading and invasion of radial growth phase and metastatic melanoma cells in a three-dimensional human skin equivalent model
PeerJ,
2017
DOI:10.7717/peerj.3754
|
|
|
[6]
|
Differential biological effects of dehydroepiandrosterone (DHEA) between mouse (B16F10) and human melanoma (BLM) cell lines
Dermato-Endocrinology,
2017
DOI:10.1080/19381980.2017.1389360
|
|
|
[7]
|
In-Vitro Inhibition of Human Melanoma (BLM) Cell Growth by Progesterone Receptor Antagonist RU-486 (Mifepristone)
Journal of Cancer Therapy,
2016
DOI:10.4236/jct.2016.713101
|
|
|
[8]
|
In-Vitro Determination of Biological and Anabolic Functions of Weak Androgen Dehydroepiandrosterone (DHEA) Using a Variety of Cell Lines
Open Journal of Endocrine and Metabolic Diseases,
2015
DOI:10.4236/ojemd.2015.58014
|
|
|